Pharmafile Logo
Pharmafocus logo
Advanced Search

UK

Showing 15 posts of 472 posts found.

brexit

The Brexit ‘cliff edge’: How life sciences can survive

June 24, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing UK, brexit, pharma

Characterised by a persistent lack of clarity and a political climate that has everyone guessing from week to week, Brexit …

Feature

One third of Brits stockpile drugs

June 24, 2019
Sales and Marketing UK, medicine, pharma, pharmaceuticals, stockpiling

A third (33%) of brits stockpile medicines, according to new research from Co-op Health. One in three British people never …

News

Alimera Sciences secures NICE recommendation for uveitis eye implant

June 21, 2019
Medical Communications, Sales and Marketing Alimera Sciences, NICE, UK, pharma, uveitis

Britain’s cost effectiveness body NICE has recommended the use of the fluocinolone acetonide implant, a new treatment option for patients …

News
28246711066_52e38bc591_z

No-deal Brexit could cause shortages and higher prices, healthcare distributors warn

June 19, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EU, UK, brexit, distribution, pharma, supply chain

The Healthcare Distribution Association (HDA) has warned MPs that Britain could face shortages of medicines if it were to leave …

News
cq5dam

AstraZeneca spends more than twice as much as expected on new HQ

June 12, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, Cambridge, UK, headquarters, pascal soriot, pharma

AstraZeneca’s new headquarters in Cambridge, United Kingdom are expected to cost more than double the sum of £330 million that …

News
shutterstock_204190579

Healthcare communications: Time to think differently with patient centricity

June 6, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NHS, Spink, UK, patient centricity, pharma

Patient centricity, derived from the NHS-driven thinking “no decision about me, without me,” has been adopted by pharma to understand …

News
donald_trump-_image_credit_gage_skidmore

Donald Trump causes confusion as to whether NHS will be ‘on the table’ in trade deal talks

June 6, 2019
Business Services, Medical Communications Donald Trump, NHS, UK, US, healthcare, pharma

President Donald Trump has caused confusion as to whether or not the NHS will ‘be on the table’ in post-Brexit …

News

Healthcare would be ‘on the table’ in post-Brexit trade negotiations with US, Trump’s ambassador says

June 3, 2019
Sales and Marketing J&J, JJ, NHS, UK, US, brexit, healthcare

The American Ambassador to the United Kingdom has said that Britain’s healthcare system would be ‘on the table’ in post-Brexit …

News
merckwindow_web

NICE recommends MSD’s Prevymis for CMV prevention following allogeneic haematopoietic stem cell transplant

May 31, 2019
Medical Communications, Sales and Marketing MSD, NICE, Prevymis, UK, cmv, cytomegalovirus, pharma

MSD has revealed that its non-nucleoside CMV inhibitor Prevymis (letermovir) has secured recommendation from NICE, meaning it will now be …

News
citylabs-banner

Manchester emerges as genomics research hub

May 29, 2019
Research and Development Diagnostics, Manchester, UK, genomics, pharma

­­Manchester, UK is emerging as a major hub for genomics research, according to a new firm set up in collaboration …

News

Mumps cases triple in England

May 24, 2019
Medical Communications MMR, UK, Vaccine, health, public health

Public Health England has urged patients to ensure that they have received the MMR vaccine after the number of cases …

News

Akcea’s Tegsedi secures NICE approval for Stage 1 or 2 polyneuropathy in hATTR

May 23, 2019
Sales and Marketing Akcea Therapeutics, NHS, NICE, Tegsedi, UK, pharma

Akcea Therapeutics’ Tegsedi (inotersen) has received recommendation from NICE, the company has revealed, meaning the therapy will now be made …

News

GP appointments should be at least 15 minutes long by 2030, report argues

May 21, 2019
Manufacturing and Production, Medical Communications GP, NHS, UK, britain, pharma

GP consultations should be five minutes longer, with 10 minute doctors’ appointments being a ‘thing of the past,’ according to …

News
celgene_building

NICE recommends Celgene’s Revlimid in treatment-naive multiple myeloma

May 20, 2019
Sales and Marketing Celgene, NICE, Revlimid, UK, multiple myeloma

Celgene’s Revlimid (lenalidomide) has been recommended by NICE for use on the NHS in England and Wales in combination with …

News

NHS England agree to pay for Biogen’s $750,000 a year SMA treatment Spinraza

May 15, 2019
Research and Development Biogen, NHS England, Spinraza, UK, pharma, sma, spinal muscular atrophy

NHS England has agreed to pay an undisclosed price for Biogen’s spinal muscle atrophy (SMA) treatment Spinraza. England’s National Health …

News
The Gateway to Local Adoption Series

Latest content

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

February 5, 2026

AstronauTx appoints Adam Rosenberg as Chair of the Board

February 5, 2026

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026